AMR

3D Printing News Unpeeled: Spee3d, Aprecia and Stratasys

AMS 2025

Share this Article

Aprecia has cooperated with Batelle to improve its binder jet technology for medicine. The company could use it to change release kinetics, make pills in a pill and patient specific medicines. The two have been working together since 2021 and this marks another deep involvement of a national lab in 3D printing. 

Spee3d is putting more cold spray 3D printers to Ukraine. The printers could be forward deployed and repair and improve kit for Ukraine. 

Stratasys has sold its Direct facility in Austin to Cumberland Additive. The firm has gone from 9 sites to 5. We’re not sure if this is a reorganization, a slimming of the business or marks a gradual exit from services for Stratasys. 

Share this Article


Recent News

Emerging AM Technologies Analysis: Where Are They Now, Part 1

3D Printing News Unpeeled: Filtering PFAS, Solid Knitting & Holographic Direct Sound Printing



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

3D Printing for Water Treatment: Ceramic Lattices to Combat ‘Forever Chemicals’

In a new study from the University of Bath, researchers have developed a new method to address the persistent issue of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in water sources. Known...

3D Printing News Briefs, June 29, 2024: AI Machine Learning, Sensory Garden, Hard Hats, & More

In 3D Printing News Briefs today, we’re starting with Desktop Metal’s new PureSinter furnace. Then it’s on to research about a variable binder amount algorithm and adaptive slicing, a 3D...

Honeywell 3D Prints Ceramic Molds for Turbine Blades

Honeywell provides turbine propulsion engines for helicopters, business aircraft, and military trainers, and has been using additive manufacturing at its lab in Phoenix for over 15 years. It now produces...

3D Printing Financials: How T&R BioFab is Balancing Innovation and Revenue Challenges

South Korean bioprinting pioneer T&R Biofab (Kosdaq: 246710) has been busy in recent months with new initiatives in regenerative medicine, collaborations, and product development. However, the company faces significant challenges...